Silver nanoparticle protein corona and toxicity: a mini-review

Journal of Nanobiotechnology

Diego Stéfani T. Martinez³  Marcela Durán¹  Camila P. Silveira²  Nelson Durán³ 

[1] Urogenital Carcinogenesis: Urogenital and Immunotherapy Laboratory, Institute of Biology, University of Campinas, Campinas, SP, Brazil;Biological Chemistry Laboratory, Institute of Chemistry, University of Campinas, CP 6154, Campinas CEP 13083-970, SP, Brazil;Brazilian Nanotechnology National Laboratory (LNNano), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP, Brazil

关键词: Cytotoxicity;    Protein corona;    Silver nanoparticles;   

Others  :  1224841
DOI  :  10.1186/s12951-015-0114-4

 received in 2015-05-05, accepted in 2015-08-08,  发布年份 2015

【 摘 要 】

Silver nanoparticles are one of the most important materials in the nanotechnology industry. Additionally, the protein corona is emerging as a key entity at the nanobiointerface; thus, a comprehensive understanding of the interactions between proteins and silver nanoparticles is imperative. Therefore, literature reporting studies involving both single molecule protein coronas (i.e., bovine and human serum albumin, tubulin, ubiquitin and hyaluronic-binding protein) and complex protein coronas (i.e., fetal bovine serum and yeast extract proteins) were selected to demonstrate the effects of protein coronas on silver nanoparticle cytotoxicity and antimicrobial activity. There is evidence that distinct and differential protein components may yield a “protein corona signature” that is related to the size and/or surface curvature of the silver nanoparticles. Therefore, the formation of silver nanoparticle protein coronas together with the biological response to these coronas (i.e., oxidative stress, inflammation and cytotoxicity) as well as other cellular biophysicochemical mechanisms (i.e., endocytosis, biotransformation and biodistribution) will be important for nanomedicine and nanotoxicology. Researchers may benefit from the information contained herein to improve biotechnological applications of silver nanoparticles and to address related safety concerns. In summary, the main aim of this mini-review is to highlight the relationship between the formation of silver nanoparticle protein coronas and toxicity.

【 授权许可】

   
2015 Durán et al.

【 图 表 】

Fig.1.

Fig.2.

Fig.3.

Fig.4.

Fig.5.

Fig.6.

Fig.7.

Fig.8.

Fig.10.

Fig.11.

Fig.12.

【 参考文献 】

• [1]Ashkarran AA, Ghavami M, Aghaverdi H, Stroeve P, Mahmoudi M. Bacterial effects and protein corona evaluations: crucial ignored factors in the prediction of bio-efficacy of various forms of silver nanoparticles. Chem Res Toxicol. 2012; 25:1231-1242.
• [2]Lem KW, Choudhury A, Lakhani AA, Kuyate P, Haw JR, Lee DS, Iqbal Z, Brumlik CJ. Use of nanosilver in consumer products. Rec Pat Nanotec. 2012; 6:60-72.
• [3]Faria AF, Martinez DST, Meira SMM, Moraes ACM, Brandelli A, Souza Filho AG, Alves OL. Anti-adhesion and antibacterial activity of silver nanoparticles supported on graphene oxide sheets. Colloid Surf B. 2014; 113:115-124.
• [4]Rai M, Kon K, Ingle A, Durán N, Galdiero S, Galdiero M. Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects. Appl Microbiol Biotechnol. 2014; 98:1951-1961.
• [5]Rai M, Ingle A, Gaikwad S, Gupta I, Yadav A, Gade A, Durán N. Fungi: myconanofactory, mycoremediation and medicine. Fungi and their applications under the series of progress in mycological research. Deshmukh SK, Misra JK, Tiwari JP, Papp T, editors. CRC Press, USA; 2015. (in press)
• [6]Tran QH, Nguyen VQ, Le AT. Silver nanoparticles: synthesis, properties, toxicology, applications and perspectives. Adv Nat Sci Nanosci Nanotechnol. 2013; 4:033001.
• [7]Han JW, Gurunathan S, Jeong J-K, Choi Y-J, Kwon D-N, Park J-K, Kim J-H. Oxidative stress mediated cytotoxicity of biologically synthesized silver nanoparticles in human lung epithelial adenocarcinoma cell line. Nanosc Res Let. 2014; 9:459. BioMed Central Full Text
• [8]Durán N, Marcato PD, De Conti R, Alves OL, Costa FTM, Brocchi M. Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action. J Braz Chem Soc. 2010; 21:949-959.
• [9]Greulich C, Diendorf J, Simon T, Eggeler G, Epple M, Koller M. Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater. 2011; 7(1):347-354.
• [10]De Lima R, Seabra AB, Durán N. Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J Appl Toxicol. 2012; 32:867-879.
• [11]Lima R, Feitosa LO, Ballottin D, Marcato PD, Tasic L, Durán N. Cytotoxicity and genotoxicity of biogenic silver nanoparticles. J Phys Conf Ser. 2013; 429:012020.
• [12]Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B. 2008; 112:13608-13619.
• [13]Park MV, Neigh AM, Vermeulen JP, de la Fonteyne LJ, Verharen HW, Briedé JJ, van Loveren H, de Jong WH. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomat. 2011; 32:9810-9817.
• [14]AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009; 3:279-290.
• [15]AshaRani PV, Hande MP, Valiyaveettil S. Anti-proliferative activity of silver nanoparticles. BMC Cell Biol. 2009; 10:65. BioMed Central Full Text
• [16]Kim Y, Suh HS, Cha HJ, Kim SH, Jeong KS, Kim DH. A case of generalized argyria after ingestion of colloidal silver solution. Am J Ind Med. 2009; 52:246-250.
• [17]Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, Ryu DY. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro. 2009; 23:1076-1084.
• [18]Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro. 2005; 19:975-983.
• [19]Hussain SM, Javorina AK, Schrand AM, Duhart HM, Ali SF, Schlager JJ. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci. 2006; 92:456-463.
• [20]Park S, Lee YK, Jung M, Kim KH, Chung N, Ahn EK, Lim Y, Lee KH. Cellular toxicity of various inhalable metal nanoparticles on human alveolar epithelial cells. Inhal Toxicol. 2007; 19:59-65.
• [21]Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci. 2005; 88:412-419.
• [22]Braydich-Stolle LK, Lucas B, Schrand A, Murdock RC, Lee T, Schlager JJ, Hussain SM, Hofmann MC. Silver nanoparticles disrupt GDNF/Fyn kinase signaling in spermatogonial stem cells. Toxicol Sci. 2010; 116:577-589.
• [23]Choi J, Reipa V, Hitchins VM, Goering PL, Malinauskas RA. Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol Sci. 2011; 123:133-143.
• [24]Cronholm P, Karlsson HL, Hedberg J, Lowe TA, Winnberg L, Elihn K, Wallinder IO, Moller L. Intracellular uptake and toxicity of Ag and CuO nanoparticles: a comparison between nanoparticles and their corresponding metal ions. Small. 2013; 9:970-982.
• [25]Grosse S, Evje L, Syversen T. Silver nanoparticle-induced cytotoxicity in rat brain endothelial cell culture. Toxicol In Vitro. 2013; 27:305-313.
• [26]Ciftci H, Turk M, Tamer U, Karahan S, Menemen Y. Silver nanoparticles: cytotoxic, apoptotic, and necrotic effects on MCF-7 cells. Turk J Biol. 2013; 37:573-581.
• [27]Faedmaleki F, Shirazi FH, Salarian A-A, Ashtiani HA, Rastegar H. Toxicity effect of silver nanoparticles on mice liver primary cell culture and HepG2 cell line. Iran J Pharm Res. 2014; 13:235-242.
• [28]Gliga AR, Skoglund S, Wallinder IO, Fadeel B, Karlsson HL. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release. Particle Fibre Toxicol. 2014; 11:11. BioMed Central Full Text
• [29]Sengstock C, Diendorf J, Epple M, Schildhauer TA, Köller M. Effect of silver nanoparticles on human mesenchymal stem cell differentiation. Beilstein J Nanotechnol. 2014; 5:2058-2069.
• [30]Massarsky A, Abraham R, Nguyen KC, Rippstein P, Tayabali AF, Trudeau VL, Moon TW. Nanosilver cytotoxicity in rainbow trout (Oncorhynchus mykiss) erythrocytes and hepatocytes. Comp Biochem Phys C. 2014; 159:10-21.
• [31]Tiwari DK, Jin T, Behari J. Dose-dependent in vivo toxicity assessment of silver nanoparticle in Wistar rats. Toxicol Mech Methods. 2011; 21:13-24.
• [32]Rahman MF, Wang J, Patterson TA, Saini UT, Robinson BL, Newport GD, Murdock RC, Schlager JJ, Hussain SM, Ali SF. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett. 2009; 187:15-21.
• [33]Kawata K, Osawa M, Okabe S. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Envir Sci Tech. 2009; 43:6046-6051.
• [34]Behra R, Sigg L, Clift MJD, Herzog F, Minghetti M, Johnston B, Petri-Fink A, Rothen-Rutishauser B. Bioavailability of silver nanoparticles and ions: from a chemical and biochemical perspective. J R Soc Interface. 2013; 10:20130396.
• [35]Wang B, Feng W, Zhao Y, Chai Z. Metallomics insights for in vivo studies of metal based nanomaterials. Metallomics. 2013; 5:793.
• [36]Comfort KK, Maurer EI, Braydich-Stolle LK, Hussain SM. Interference of silver, gold, and iron oxide nanoparticles on epidermal growth factor signal transduction in epithelial cells. ACS Nano. 2011; 5:10000-10008.
• [37]Stevanovic M, Kovacevic B, Petkovic J, Filipic M, Uskokovic D. Effect of poly-alpha, gamma, l-glutamic acid as a capping agent on morphology and oxidative stress-dependent toxicity of silver nanoparticles. Int J Nanomed. 2011; 6:2837-2847.
• [38]Stevanovic M, Uskokovic V, Filipovic M, Skapin SD, Uskokovic D. Composite PLGA/AgNpPGA/AscH nanospheres with combined osteoinductive, antioxidative, and antimicrobial activities. ACS Appl Mater Interfaces. 2013; 5:9034-9042.
• [39]Filipović N, Stevanović M, Radulović A, Pavlović V, Uskoković D. Facile synthesis of poly(ε-caprolactone) micro and nanospheres using different types of polyelectrolytes as stabilizers under ambient and elevated temperature. Compos Part B. 2013; 45:1471-1479.
• [40]Chairuangkitti P, Lawanprasert S, Roytrakul S, Aueviriyavit S, Phummiratch D, Kulthong K, Chanvorachote P, Maniratanachote R. Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways. Toxicol In Vitro. 2013; 27:330-338.
• [41]Shannahan JH, Podila R, Aldossari AA, Emerson H, Powell BA, Ke PC, Rao AM, Brown JM. Formation of a protein corona on silver nanoparticles mediates cellular toxicity via scavenger receptors. Toxicol Sci. 2015; 143:136-146.
• [42]Miclăuş T, Bochenkov VE, Ogaki R, Howard KA, Sutherland DS. Spatial mapping and quantification of soft and hard protein coronas at silver nanocubes. Nano Lett. 2014; 14(4):2086-2093.
• [43]Lee YK, Choi E-J, Webster TJ, Kim S-H, Khang D. Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity. Inter J Nanomed. 2015; 10:97-113.
• [44]Linse S, Cabaleiro-Lago C, Xue W-F, Lynch I, Lindman S, Thulin E, Radford SE, Dawson KA. Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci USA. 2007; 104:8691-8696.
• [45]Cukalevski R, Lundqvist M, Oslakovic C, Dahlback B, Linse S, Cedervall T. Structural changes in apolipoproteins bound to nanoparticles. Langmuir. 2011; 27:14360-14369.
• [46]Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. What the cell “sees” in bionanoscience. J Am Chem Soc. 2010; 132:5761-5768.
• [47]Monopoli MP, Åberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol. 2012; 7:779-786.
• [48]Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, Dawson KA, Linse S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA. 2007; 104:2050-2055.
• [49]Klein J. Probing the interactions of proteins and nanoparticles. Proc Natl Acad Sci USA. 2007; 104:2029-2030.
• [50]Rocker C, Potzl M, Zhang F, Parak WJ, Nienhaus GU. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat Nanotechnol. 2009; 4:577-580.
• [51]Treuel L, Malissek M, Gebauer JS, Zellner R. The influence of surface composition of nanoparticles on their interactions with serum albumin. Chem Phys Chem. 2010; 11:3093-3099.
• [52]Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, Knauer SK, Bantz C, Nawroth T, Bier C, Sirirattanapan J, Mann W, Treuel L, Zellner R, Maskos M, Schild H, Stauber RH. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano. 2011; 5:7155-7167.
• [53]Monopoli MP, Baldelli Bombelli F, Dawson KA. Nanobiotechnology: nanoparticle coronas take shape. Nat Nanotechnol. 2011; 6:11-12.
• [54]Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, Dawson KA. Physical–chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc. 2011; 133:2525-2534.
• [55]Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF. Differential plasma protein binding to metal oxide nanoparticles. Nanotech. 2009; 20:455101-455109.
• [56]Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA. 2008; 105:14265-14270.
• [57]Lesniak A, Fenaroli F, Monopoli MP, Abberg C, Dawson KA, Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano. 2012; 6:5845-5857.
• [58]Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S. Protein-nanoparticle interactions: opportunities and challenges. Chem Rev. 2011; 111:5610-5637.
• [59]Delpino P, Pelaz B, Zhang Q, Maffre P, Nienhaus GU, Parak WJ. Protein corona formation around nanoparticles—from the past to the future. Mater Horiz. 2014; 1:301-313.
• [60]Durán N, Marcato PD, Durán M, Yadav A, Gade A, Rai M. Mechanistic aspects in the biogenic synthesis of extracellular metal nanoparticles by peptides, bacteria, fungi, and plants. Appl Microbiol Biotechnol. 2011; 90:1609-1624.
• [61]Durán N, Marcato PD. Biotechnological routes to metallic nanoparticles production: mechanistic aspects, antimicrobial activity, toxicity and industrial applications. In: Nano-antimicrobials: progress and prospects. Rai M, Cioffi N, editors. Springer, Germany; 2012: p.337-374. (Part 3)
• [62]Balachandran YL, Girija S, Selvakumar R, Tongpim S, Gutleb AC, Suriyanarayanan S. Differently environment stable bio-silver nanoparticles: study on their optical enhancing and antibacterial properties. PLoS One. 2013; 8:e77043.
• [63]Eckhardt S, Brunetto PS, Gagnon J, Priebe M, Giese B, Fromm KM. Nanobio silver: it’s interactions with peptides and bacteria, and it’s uses in medicine. Chem Rev. 2013; 113:4708-4754.
• [64]Edmundson MC, Capeness M, Horsfall L. Exploring the potential of metallic nanoparticles within synthetic biology. New Biotechn. 2014; 31:572-578.
• [65]SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks) (2014) Nanosilver: safety, health and environmental effects and role in antimicrobial resistance. http://ec.europa.eu/dgs/health_consumer/dyna/enews/enews.cfm?al_id=1494. Accessed June 2014
• [66]Treuel L, Malissek M, Grass S, Diendorf J, Mahl D, Meyer-Zaika W, Epple M. Quantifying the influence of polymer coatings on the serum albumin corona formation around silver and gold nanoparticles. J Nanopart Res. 2012; 14:1-12.
• [67]Ravindran A, Singh A, Raichur AM, Chandrasekaran N, Mukherjee A. Studies on interaction of colloidal Ag nanoparticles with bovine serum albumin (BSA). Colloids Surf B Biointerfaces. 2010; 76:32-37.
• [68]Mariam J, Dongre P, Kothari D. Study of interaction of silver nanoparticles with bovine serum albumin using fluorescence spectroscopy. J Fluoresc. 2011; 21:2193-2199.
• [69]Podila R, Chen R, Ke PC, Brown JM, Rao AM. Effects of surface functional groups on the formation of nanoparticle-protein corona. Appl Phys Lett. 2012; 101:263701.
• [70]Shannahan JH, Lai X, Ke PC, Podila R, Brown JM, Witzmann FA. Silver nanoparticle protein corona composition in cell culture media. PLoS One. 2013; 8:e74001.
• [71]Kittler S, Greulich C, Gebauer JS, Diendorf J, Treuel L, Ruiz LJM, Gonzalez-Calbet JM, Vallet-Regi M, Zellner R, Koller M, Epple M. The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles. J Mater Chem. 2010; 20:512-518.
• [72]Kittler S, Greulich C, Diendorf J, Köller M, Epple M. Toxicity of silver nanoparticles increases during storage due to slow dissolution under release of silver ions. Chem Mater. 2010; 22:4548-4554.
• [73]Liu R, Sun F, Zhang L, Zong W, Zhao X, Wang L, Wu R, Hao X. Evaluation on the toxicity of nanoAg to bovine serum albumin. Sci Total Environ. 2009; 407:4184-4188.
• [74]Casals E, Pfaler T, Duschl A, Oostingh GJ, Puntes VF. Hardening of the nanoparticle–protein corona in metal (Au, Ag) and oxide (Fe 3 O 4 , CoO, and CeO 2 ) nanoparticles. Small. 2011; 7:3479-3486.
• [75]Laloy J, Minet V, Alpan L, Mullier F, Beken S, Toussaint O, Lucas S, Dogné J-M. Impact of silver nanoparticles on haemolysis, platelet function and coagulation. Nanobiomedicine. 2014; 1:1-9.
• [76]Saptarshi SR, Duschl A, Lopata AL. Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotech. 2013; 11:1-12. BioMed Central Full Text
• [77]Pearson RM, Juettner VV, Hong S. Biomolecular corona on nanoparticles: a survey of recent literature and it implications in targeted drug delivery. Front Chem. 2014; 2:1-7.
• [78]Beneti F, Fedel M, Minati L, Speranza G, Migliaresi C. Gold nanoparticles: role of size and surface chemistry on blood protein adsorption. J Nanopart Res. 2013; 15(1694):1-9.
• [79]Sakulkhu U, Mahmoudi M, Maurizi L, Salaklang J, Hofmann H. Protein corona composition of superparamagnetic iron oxide nanoparticles with various physico-chemical properties and coatings. Sci Reports. 2014; 4:1-9.
• [80]Feng S, Lin D, Lin J, Li B, Huang Z, Chen G, Zhang W, Wang L, Pan J, Chen R, Zeng H. Blood plasma surface-enhanced Raman spectroscopy for non-invasive optical detection of cervical cancer. Analyst. 2013; 138:3967-3974.
• [81]Gebauer JS, Malissek M, Simon S, Knauer SK, Maskos M, Stauber RH, Peukert W, Treuel L. Impact of the nanoparticle–protein corona on colloidal stability and protein structure. Langmuir. 2012; 28:9673-9679.
• [82]Chen R, Choudhary P, Schurr RN, Bhattacharya P, Brown JM, Ke PC. Interaction of lipid vesicle with silver nanoparticle-serum albumin protein corona. Appl Phys Lett. 2012; 100:013703.
• [83]Monteiro-Riviere NA, Samberg ME, Oldenburg SJ, Riviere JE. Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations? Toxicol Lett. 2013; 220:286-293.
• [84]Wen Y, Geitner NK, Chen R, Ding F, Chen P, Andorfer RE, Govindan PN, Ke PC. Binding of cytoskeletal proteins with silver nanoparticles. RSC Adv. 2013; 3:22002-22007.
• [85]Ding F, Radic S, Choudhary P, Chen R, Brown JM, Pu Chun Ke PC. Direct observation of silver nanoparticle-ubiquitin corona formation. Nanosc. 2013; 5:9162-9169.
• [86]Walkey CD, Olsen JB, Song F, Liu R, Guo H, Olsen DWH, Cohen Y, Emili A, Chan WCW. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano. 2014; 8:2439-2455.
• [87]Eigenheer R, Castellanos ER, Nakamoto MY, Gerner KT, Lampeb AM, Wheeler KE. Silver nanoparticle protein corona composition compared across engineered particle properties and environmentally relevant reaction conditions. Environ Sci Nano. 2014; 1:238-247.
• [88]Gnanadhas DP, Thomas MB, Thomas R, Raichur AM, Chakravortty D. Interaction of silver nanoparticles with serum proteins affects their antimicrobial activity in vivo. Antimicrob Agents Chemother. 2013; 57:4945-4955.
• [89]Kennedy DC, Orts-Gil G, Lai C-H, Moller L, Haase A, Luch A, Seeberger PH. Carbohydrate functionalization of silver nanoparticles modulates cytotoxicity and cellular uptake. J Nanobiotechnol. 2014; 12:59. BioMed Central Full Text